Beam Therapeutics (BEAM) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Beam Therapeutics (BEAM) over the last 6 years, with Q3 2025 value amounting to 0.04.
- Beam Therapeutics' Asset Utilization Ratio fell 8565.86% to 0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04, marking a year-over-year decrease of 8565.86%. This contributed to the annual value of 0.05 for FY2024, which is 8162.28% down from last year.
- Per Beam Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.04 for Q3 2025, which was down 8565.86% from 0.04 recorded in Q2 2025.
- In the past 5 years, Beam Therapeutics' Asset Utilization Ratio ranged from a high of 0.29 in Q3 2024 and a low of 0.0 during Q2 2021
- In the last 5 years, Beam Therapeutics' Asset Utilization Ratio had a median value of 0.05 in 2022 and averaged 0.09.
- In the last 5 years, Beam Therapeutics' Asset Utilization Ratio surged by 17692934.48% in 2022 and then tumbled by 8565.86% in 2025.
- Quarter analysis of 5 years shows Beam Therapeutics' Asset Utilization Ratio stood at 0.04 in 2021, then increased by 14.85% to 0.05 in 2022, then skyrocketed by 506.87% to 0.27 in 2023, then plummeted by 79.67% to 0.06 in 2024, then fell by 26.17% to 0.04 in 2025.
- Its last three reported values are 0.04 in Q3 2025, 0.04 for Q2 2025, and 0.05 during Q1 2025.